SCHEMBL19259236

SCHEMBL19259236

O=COCC1(C(=O)OCc2ccccc2)CCC(=O)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.48
CRBN Q96SW2 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HCAR2 Q8TDS4 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GLA P06280 1/20 0.38
MAPK1 P28482 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19208963 0.82 DDB1 (0.53) DDB1CRBNL3MBTL1ALDH1A1CYP3A4
SCHEMBL19208947 0.82 KMT2A (0.55) DDB1CRBNL3MBTL1NPC1RAB9A
SCHEMBL3654430 0.81 DDB1 (0.52) DDB1CRBNL3MBTL1ALDH1A1CYP3A4
SCHEMBL16875197 0.81 DDB1 (0.52) DDB1CRBNL3MBTL1ALDH1A1CYP3A4
SCHEMBL25787780 0.78 DDB1 (0.57) DDB1CRBNL3MBTL1ALDH1A1CYP3A4
SCHEMBL18650 0.77 LMNA (0.45) DDB1CRBNNPC1RAB9AALDH1A1
SCHEMBL3021875 0.75 DDB1 (0.55) DDB1CRBNL3MBTL1ALDH1A1CYP3A4
SCHEMBL2706742 0.74 DDB1 (0.47) DDB1CRBNL3MBTL1NPC1RAB9A
SCHEMBL15967719 0.74 DDB1 (0.50) DDB1CRBNL3MBTL1NPC1RAB9A
SCHEMBL23135459 0.74 ALDH1A1 (0.50) DDB1CRBNL3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3411381-B1 C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS VIIV HEALTHCARE UK NO 5 LTD (GB) 2021-01-20 EP disclosed
WO-2017134596-A1 C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS VIIV Healthcare UK (No.5) Limited (GB) 2017-08-10 WO disclosed